The invention relates to a pharmaceutical composition in the form of a capsule, comprising a powder mixture comprising silodosin. The invention also relates to the use of said formulation in the treatment of dysuria and/or benign prostatic hyperplasia and to a method for the manufacture of the composition comprising mixing the excipients and silodosin in a single powder mixture or blend and direct filling into a capsule.
